AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32338932 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative cognitive‐affective therapy for BED (ICAT‐BED)
Number of subjects: 112
Study 32338932 — intervention group
Group type: COMPARATOR
Intervention: Guided self-help cognitive-behavioral therapy (CBTgsh)
Number of subjects: 112
Study 35262490 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention using 2 mobile apps (WeChat and Message Express) for 60 days followed by 30 days of nonintervention follow-up.
Number of subjects: 230
Study 35262490 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (experimental group)
Number of subjects: 230
Study 35262490 — intervention group
Group type: COMPARATOR
Intervention: Control group (only received educational materials)
Number of subjects: 230
Study 33092527 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical dexmedetomidine instillation (0.5 μg/kg and normal saline 20 mL)
Number of subjects: 167
Study 33092527 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (20 mL)
Number of subjects: 167
Study 35188053 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day DM clinic intervention (n=509)
Number of subjects: 930
Study 34429002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with allergen extracts of D. pteronyssinus and D. farinae (50/50%) in SQ-HDM SLIT tablets
Number of subjects: 32
Study 34429002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34429002 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 32
Study 35367007 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for 17 cycles
Number of subjects: 976
Study 35367007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 976
Study 34120122 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone call
Number of subjects: 306
Study 34120122 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS
Number of subjects: 306
Study 34120122 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 306
Study 35279331 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic Music Group
Number of subjects: 0
Study 35279331 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Selected Group
Number of subjects: 0
Study 35279331 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study 32070388 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (n=15)
Number of subjects: 30
Study 32070388 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (Control) (n=15)
Number of subjects: 30
Study 34187535 — intervention group
Group type: EXPERIMENTAL
Intervention: Gegen Qinlian decoction granules + Erbai drink placebo
Number of subjects: 120
Study 34187535 — intervention group
Group type: EXPERIMENTAL
Intervention: Erbai drink granules + Gegen Qinlian decoction placebo
Number of subjects: 120
Study 34187535 — intervention group
Group type: COMPARATOR
Intervention: basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo
Number of subjects: 120
Study 36096979 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate revascularization
Number of subjects: 1171
Study 36096979 — intervention group
Group type: COMPARATOR
Intervention: Staged revascularization
Number of subjects: 1171
Study 33301997 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based Management + TAU
Number of subjects: 2000
Study 33301997 — intervention group
Group type: EXPERIMENTAL
Intervention: iFightDepression-Survive + TAU
Number of subjects: 2000
Study 33301997 — intervention group
Group type: EXPERIMENTAL
Intervention: Self Awareness of Mental Health + TAU
Number of subjects: 2000
Study 33301997 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 2000
Study 32107452 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension risk-prediction model
Number of subjects: 9034
Study 33075031 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Moms intervention (12-week mindful physical activity using prenatal yoga)
Number of subjects: 0
Study 33075031 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Moms intervention
Number of subjects: 0
Study 35577169 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime HRV
Number of subjects: 68
Study 35577169 — intervention group
Group type: COMPARATOR
Intervention: Nighttime HRV
Number of subjects: 68
Study 35577169 — intervention group
Group type: COMPARATOR
Intervention: Previous nights' sleep measures
Number of subjects: 68
Study 33439727 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (second-line therapy)
Number of subjects: 1025
Study 35543372 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous mRNA booster (BNT162b2 + BNT162b2 + mRNA-1273; 'BBM')
Number of subjects: 100
Study 35543372 — intervention group
Group type: COMPARATOR
Intervention: Homologous booster (BNT162b2 + BNT162b2 + BNT162b2; 'BBB')
Number of subjects: 100
Study 33939794 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 8196
Study 33939794 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking (adjusted)
Number of subjects: 8196
Study 33939794 — intervention group
Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 8196
Study 33939794 — intervention group
Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 8196
Study 32886108 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 g mycoprotein (31.5 g protein; MYCO; n = 10)
Number of subjects: 19
Study 32886108 — intervention group
Group type: COMPARATOR
Intervention: 35 g BCAA-enriched mycoprotein (18.7 g protein; ENR; n = 9)
Number of subjects: 19
Study 35916747 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% Vmax
Number of subjects: 12
Study 35916747 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% Vmax
Number of subjects: 12
Study 35916747 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% Vmax
Number of subjects: 12
Study 35916747 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% Vmax
Number of subjects: 12
Study 34518481 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (5,000 IU/day)
Number of subjects: 66
Study 34518481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 34518481 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 66
Study 33091614 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 73
Study 33091614 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 73
Study 33091614 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 73
Study 32808025 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-anodal tDCS over the PFC regions (2 mA, 20 minutes, twice daily for 5 weeks)
Number of subjects: 60
Study 32808025 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study 35039258 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (erythromycin sequential therapy plus azithromycin)
Number of subjects: 93
Study 35039258 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 93
Study 32447194 — intervention group
Group type: EXPERIMENTAL
Intervention: PCL‐6 positive screening (score ≥14)
Number of subjects: 767
Study 32447194 — intervention group
Group type: EXPERIMENTAL
Intervention: CIDI positive screening (score ≥8)
Number of subjects: 767
Study 32447194 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCL‐6 and CIDI positive screening
Number of subjects: 767
Study 32447194 — intervention group
Group type: COMPARATOR
Intervention: PCL‐6
Number of subjects: 767
Study 32447194 — intervention group
Group type: COMPARATOR
Intervention: CIDI
Number of subjects: 767
Study 34856641 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 23
Study 34856641 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 33712076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 0.6 mg/kg
Number of subjects: 120
Study 33712076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 0.8 mg/kg
Number of subjects: 120
Study 33712076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 1.0 mg/kg
Number of subjects: 120
Study 33712076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 1.2 mg/kg
Number of subjects: 120
Study 33712076 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 1.4 mg/kg
Number of subjects: 120
Study 33712076 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine 0.1 mg/kg (reference dose)
Number of subjects: 120
Study 32112365 — intervention group
Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 24
Study 32112365 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 24
Study 32112365 — intervention group
Group type: EXPERIMENTAL
Intervention: Curry leaf
Number of subjects: 24
Study 32112365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35848821 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 5% dextrose prolotherapy
Number of subjects: 54
Study 35848821 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (1 ml triamcinolone 40 mg/ml)
Number of subjects: 54
Study 33672963 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g acacia gum
Number of subjects: 48
Study 33672963 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g acacia gum
Number of subjects: 48
Study 33672963 — intervention group
Group type: COMPARATOR
Intervention: 0 g acacia gum (control)
Number of subjects: 48
Study 32620024 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 0
Study 32620024 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 0
Study 32998848 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro‐training (4 endurance and 4 strength training sessions lasting 15 min each)
Number of subjects: 290
Study 32998848 — intervention group
Group type: COMPARATOR
Intervention: Control‐training (2 sessions of standard military training lasting 60 min each)
Number of subjects: 290
Study 32998848 — intervention group
Group type: COMPARATOR
Intervention: Classical‐training (1 strength and 1 endurance session lasting 60 min each)
Number of subjects: 290
Study 33604801 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (60 to 70% of maximal heart rate, 30 to 45 min/day, 3 sessions/week for 12 weeks)
Number of subjects: 30
Study 33604801 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 30
Study 36318050 — intervention group
Group type: EXPERIMENTAL
Intervention: One-session treatment
Number of subjects: 268
Study 36318050 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy
Number of subjects: 268
Study 32385847 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (CHAT) with tailored health messages
Number of subjects: 22
Study 32385847 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tailored health messages)
Number of subjects: 22
Study 35585571 — intervention group
Group type: EXPERIMENTAL
Intervention: Social care nurses' continuous involvement in acute oncology wards
Number of subjects: 362
Study 35585571 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 362
Study 32889858 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36107435 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial weight management program
Number of subjects: 0
Study 36107435 — intervention group
Group type: COMPARATOR
Intervention: Do-it-yourself (DIY) approach
Number of subjects: 0
Study 34775994 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback from the Anxiety Meter
Number of subjects: 28
Study 34775994 — intervention group
Group type: COMPARATOR
Intervention: No feedback from the Anxiety Meter
Number of subjects: 28
Study 33160433 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Assisted Learning workshop
Number of subjects: 104
Study 33160433 — intervention group
Group type: COMPARATOR
Intervention: Control group (sixth year students)
Number of subjects: 104
Study 35493437 — intervention group
Group type: EXPERIMENTAL
Intervention: iCT-SAD (internet Cognitive Therapy programme)
Number of subjects: 44
Study 35493437 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 44
Study 33877942 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (DB)
Number of subjects: 0
Study 35600872 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibetan herbal pain-relieving plaster (Tibetree Pain-Relieving Plaster) applied daily for 14 days
Number of subjects: 0
Study 35600872 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch applied daily for 14 days
Number of subjects: 0
Study 35600872 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibetan herbal pain-relieving plaster (Tibetree Pain-Relieving Plaster)
Number of subjects: 0
Study 35600872 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study 33320850 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein-based multiingredient nutritional supplement
Number of subjects: 0
Study 33320850 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35325149 — intervention group
Group type: EXPERIMENTAL
Intervention: Osilodrostat
Number of subjects: 73
Study 35325149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 35032932 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital CMV educational intervention
Number of subjects: 20
Study 33288467 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy (CBT) with telephone support
Number of subjects: 638
Study 33288467 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy (CBT) without telephone support
Number of subjects: 638
Study 33288467 — intervention group
Group type: COMPARATOR
Intervention: Online Psychoeducation
Number of subjects: 638
Study 35179757 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CXL
Number of subjects: 79
Study 35179757 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated CXL
Number of subjects: 79
Study 35179757 — intervention group
Group type: COMPARATOR
Intervention: Control (Standard CXL)
Number of subjects: 79
Study 33707061 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 µg mRNA-1273
Number of subjects: 600
Study 33707061 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg mRNA-1273
Number of subjects: 600
Study 33707061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study 33707061 — intervention group
Group type: EXPERIMENTAL
Intervention: Both 50 µg and 100 µg mRNA-1273
Number of subjects: 600
Study 36350787 — intervention group
Group type: EXPERIMENTAL
Intervention: CamAPS FX hybrid closed-loop (HCL)
Number of subjects: 74
Study 36350787 — intervention group
Group type: COMPARATOR
Intervention: Sensor augmented pump (control)
Number of subjects: 74
Study 32541326 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine (for 6 months)
Number of subjects: 0
Study 32541326 — intervention group
Group type: COMPARATOR
Intervention: None (control group from prospective randomized trials)
Number of subjects: 0
Study 34439165 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant induction anti-HER2 therapy with lapatinib and trastuzumab followed by weekly paclitaxel plus anti-HER2 therapy.
Number of subjects: 212
Study 34439165 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CpCR plus ypN0 after neoadjuvant treatment.
Number of subjects: 212
Study 32036576 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ketogenic diet (MKD)
Number of subjects: 12
Study 32036576 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium chain triglyceride ketogenic diet (MCTKD)
Number of subjects: 12
Study 32036576 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study 32036576 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial participation
Number of subjects: 12
Study 32036576 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient decision-making
Number of subjects: 12
Study 32036576 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet burden and quality of life
Number of subjects: 12
Study 33866828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796
Study 33866828 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 4796
Study 35115359 — intervention group
Group type: EXPERIMENTAL
Intervention: Benfotiamine 300 mg two times a day for 12 months
Number of subjects: 60
Study 35115359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33751615 — intervention group
Group type: EXPERIMENTAL
Intervention: DGG + TUN
Number of subjects: 27
Study 33751615 — intervention group
Group type: COMPARATOR
Intervention: SCTG + TUN
Number of subjects: 27
Study 33751615 — intervention group
Group type: COMPARATOR
Intervention: SCTG samples
Number of subjects: 27
Study 32893717 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 6820
Study 35330577 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS)
Number of subjects: 49
Study 33844575 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred vaccination via blinded crossover (original vaccine group receives placebo and vice versa)
Number of subjects: 0
Study 33844575 — intervention group
Group type: COMPARATOR
Intervention: Placebo group receiving the efficacious vaccine after initial trial
Number of subjects: 0
Study 33283550 — intervention group
Group type: EXPERIMENTAL
Intervention: Active magnets placed over the ulnar and median nerves at the wrist for 30 minutes.
Number of subjects: 12
Study 33283550 — intervention group
Group type: COMPARATOR
Intervention: Sham magnets placed at corresponding sites on the other arm for 30 minutes.
Number of subjects: 12
Study 32165549 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app
Number of subjects: 90
Study 32165549 — intervention group
Group type: COMPARATOR
Intervention: Active control app (muscle relaxation techniques)
Number of subjects: 90
Study 32165549 — intervention group
Group type: COMPARATOR
Intervention: Usual care without app
Number of subjects: 90
Study 35024875 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscrew-facilitated micro-osteoperforations (MOPs) applied to the extraction area
Number of subjects: 20
Study 35024875 — intervention group
Group type: COMPARATOR
Intervention: Control side (no MOPs)
Number of subjects: 20
Study 34406870 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole breast irradiation (radiation therapy [RT])
Number of subjects: 636
Study 34406870 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 636
Study 35271241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training in addition to drug therapy
Number of subjects: 60
Study 35271241 — intervention group
Group type: COMPARATOR
Intervention: Control group (drug therapy only)
Number of subjects: 60
Study 32185662 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide 0.3 mg
Number of subjects: 951
Study 32185662 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide 3.0 mg
Number of subjects: 951
Study 32185662 — intervention group
Group type: EXPERIMENTAL
Intervention: Plecanatide (0.3 mg and 3.0 mg)
Number of subjects: 951
Study 32185662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 951
Study 36283418 — intervention group
Group type: EXPERIMENTAL
Intervention: Full version of the mHealth app (Roadmap) with resilience-building activities
Number of subjects: 30
Study 36283418 — intervention group
Group type: COMPARATOR
Intervention: Control version of the mHealth app (limited view without resilience-building activities)
Number of subjects: 30
Study 32453224 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 0
Study 32453224 — intervention group
Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 0
Study 35033928 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (liraglutide) after 10 days
Number of subjects: 0
Study 35033928 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (liraglutide) after 12 weeks
Number of subjects: 0
Study 35033928 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0
Study 33187535 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote dietitian supervised dietary and physical activity intervention via mobile app
Number of subjects: 60
Study 33187535 — intervention group
Group type: COMPARATOR
Intervention: Clinical standard of care (nutritionist and/or physical therapy referrals)
Number of subjects: 60
Study 35509857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation training
Number of subjects: 60
Study 35509857 — intervention group
Group type: COMPARATOR
Intervention: Artificial intelligence algorithm for ultrasonic image processing
Number of subjects: 60
Study 35509857 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine guidance and postpartum health education)
Number of subjects: 60
Study 32311110 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg dapagliflozin
Number of subjects: 0
Study 32311110 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher than 10 mg dapagliflozin
Number of subjects: 0
Study 36052978 — intervention group
Group type: EXPERIMENTAL
Intervention: Capacity building program for key workers to support parental wellbeing; 12-month intervention program including tailored professional development, resource development, and sustainability measures.
Number of subjects: 0
Study 36052978 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 33155105 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol administration at standard dose during coronary CT angiography (CCTA)
Number of subjects: 1009
Study 32965318 — intervention group
Group type: EXPERIMENTAL
Intervention: Book-mediated educational intervention
Number of subjects: 56
Study 32965318 — intervention group
Group type: COMPARATOR
Intervention: Verbal guidance (control)
Number of subjects: 56